XSHE
002562
Market cap938mUSD
Dec 05, Last price
6.50CNY
1D
1.88%
1Q
0.31%
Jan 2017
-13.91%
IPO
48.57%
Name
Brother Enterprises Holding Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Brother Enterprises Holding Co.,Ltd. engages in the production and sale of leather chemicals in China and internationally. It operates in four divisions: Leather Chemicals, Vitamins, Spices, and Active Pharmaceutical Ingredients. The company offers vitamin nutritional additives, including vitamin K3, vitamin B1, nicotinamide, niacin, vitamin B5, and alanine; leather chemicals, such as chrome tanning agents, retanning agents, fatliquors, additives, etc.; and active pharmaceutical ingredients (API) comprising contrast agent APIs, topiroxostat, and the custom-made APIs and intermediates for endocrine and metabolism, nerves, respiratory and other therapeutic areas. It also provides flavors and fragrances, which include vanillin, ethyl vanillin, and other synthetic fragrances, as well as turpentine for food, daily chemical, and other industries; molecular sieves and catalysts; and sodium dichromate, chromic acid, and chrome tanning agent. The company was formerly known as Haining Leather Chemicals Factory. Brother Enterprises Holding Co.,Ltd. was founded in 1991 and is headquartered in Haining, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||